⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,827.35
−0.41%
FTSE ADX
9,809.64
+0.27%
TASI
9,950.91
−1.71%
QE Index
8,585.94
−0.54%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,278.61
−0.41%
DFM:EMIRATESNBD
AED 31.64
+0.44%
ADX:IHC
AED 357.10
+1.45%
SAU:2222
SAR 25.52
−1.09%
DSMD:QNBK
QAR 15.44
−1.40%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.42
−0.02%
Gold
$4,115.02
−0.62%
Brent
$111.16
+1.78%
BTC
$81,498.76
−0.42%
ETH
$2,386.10
−0.79%
DFM General
5,827.35
−0.41%
FTSE ADX
9,809.64
+0.27%
TASI
9,950.91
−1.71%
QE Index
8,585.94
−0.54%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,278.61
−0.41%
DFM:EMIRATESNBD
AED 31.64
+0.44%
ADX:IHC
AED 357.10
+1.45%
SAU:2222
SAR 25.52
−1.09%
DSMD:QNBK
QAR 15.44
−1.40%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.42
−0.02%
Gold
$4,115.02
−0.62%
Brent
$111.16
+1.78%
BTC
$81,498.76
−0.42%
ETH
$2,386.10
−0.79%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Open
🇸🇦
Saudi Arabia
Tadawul · TASI
Open
🇶🇦
Qatar
QSE · QE General
Open
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Open
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NAS
› GILD
G
Gilead Sciences Inc
NAS:GILD
Healthcare
CBOE:SPESG
NASDAQ:NBI
$153.07
−2.00%
At close
At close · Tue 20 Oct · ≈
AED 562.15
· Market cap
$189.8B
· Next earnings
Thu 29 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
Gilead Sciences Inc · News · TradingHolo
GILD news
Headlines tagged to this company
SE
Gilead hits mid-stage trial success for oral bowel disease therapy
Seeking Alpha · 20 h ago
BU
Gilead to Present New Data Across HIV and Emerging Antiviral Research at IDWeek 2026
BusinessWire · 22 h ago
RE
Gilead - Emvistegrast 200 Mg Met The Primary Endpoint In Phase 2 Swift Dose-Ranging Study
Reuters · 23 h ago
RE
Gilead's pill succeeds in mid-stage bowel disease trial
Reuters · 24 h ago
ST
Stocktwits Biotech Dealmaker: Gilead, AstraZeneca And Roche Chase Pipeline Expansion Over Buyouts
Stocktwits · 3 d ago
BU
Gilead Sciences to Release Third Quarter 2026 Financial Results on Thursday, October 29, 2026
BusinessWire · 5 d ago
TR
GILD Q3'26 Earnings: revenue estimate is 7.79B USD
TradingView · 5 d ago
DO
Vir Biotechnology Shares Jump on Gilead Cancer Collaboration
Dow Jones Newswires · 6 d ago
RE
Vir, Gilead team up on solid tumor cancer therapies in up to $1.9 billion deal
Reuters · 6 d ago
SE
Vir jumps on Gilead licensing deal worth up to $1.9B for cancer drugs
Seeking Alpha · 6 d ago
BU
Vir Biotechnology Enters Multi-Program Collaboration and License Agreement with Gilead Sciences to Discover and Develop Novel PRO-XTEN® Dual-masked T-cell Engagers for Solid Tumors
BusinessWire · 6 d ago
DO
Gilead Sciences Is Maintained at Sector Perform by RBC Capital
Dow Jones Newswires · 12 d ago
DO
Gilead Sciences Price Target Maintained With a $155.00/Share by Cantor Fitzgerald
Dow Jones Newswires · 12 d ago
DO
Gilead Sciences Price Target Raised to $158.00/Share From $150.00 by Truist Securities
Dow Jones Newswires · 13 d ago
DO
Gilead Sciences Is Maintained at Overweight by JP Morgan
Dow Jones Newswires · 13 d ago
DO
Gilead Sciences Price Target Cut to $163.00/Share From $165.00 by Morgan Stanley
Dow Jones Newswires · 13 d ago
RE
Cognizant Expands Ai-Enabled Devops Capabilities For Gilead Sciences
Reuters · 14 d ago
RE
Global healthcare companies invest billions to boost US presence
Reuters · 14 d ago
RE
Nurix Extends Gilead Collaboration For Oncology Program
Reuters · 15 d ago
More news →